Highlights the potential for unusually severe evolution and fatal outcomes in CA-MSSA endocarditis, suggesting limited efficacy of vancomycin in some cases.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rapid progression risks in CA-MSSA native valve endocarditis; leaves open optimal adjunctive strategies for persistent SAB.
BACKGROUND: Over the last decades Staphylococcus aureus (SA) has become the dominant etiology of native valve infective endocarditis, with the community-acquired methicillin-sensible Staphylococcus aureus (CA-MSSA) strains being the prevailing type. CASE: We report here a case of extremely severe CA-MSSA aortic valve acute endocarditis associated with persistent Staphylococcus aureus bacteremia (SAB) in a previously healthy man and include a literature review.The patient developed severe and rare complications (purpura, purulent pericarditis, intracerebral hematoma, and rhabdomyolysis) through systemic embolism; they required drainage of pericardial empyema and cerebral hematoma, the latter eventually caused a fatal outcome. The strains recovered from sequential blood culture sets and pericardial fluid were MSSA negative for genes encoding for staphylococcal toxic shock syndrome toxin (TSST)-1 and Panton-Valentine leukocidin. C, G, and I enterotoxin genes were detected. CONCLUSIONS: This case with unusually severe evolution underlines the limited ability of vancomycin to control some MSSA infections, possibly due to potential involvement of SA virulence factors, hence the importance of clinical vigilance for community SAB cases.
No takes yet. Share an insight, caveat, or question.
Georgescu et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: